When was enVVeno Medical Corporation stock made available for the first time to the public?

The IPO Date for enVVeno Medical Corporation is 2021-02-18. On this 2021-02-18, enVVeno Medical Corporation stock was made publicly available.

Where is the headquarters of enVVeno Medical Corporation stock?

Headquarters information for enVVeno Medical Corporation is currently unavailable. We'll update this as soon as it's available.

What industry does enVVeno Medical Corporation belong to?

The enVVeno Medical Corporation belongs to Medical - Specialties.

enVVeno Medical Corporation

NVNBW•PNK

Healthcare

Medical - Specialties

$0.40

$0.10(33.33%)

enVVeno Medical Corporation (NVNBW) Company Profile & Overview

Explore enVVeno Medical Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

enVVeno Medical Corporation (NVNBW) Company Profile & Overview

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

SectorHealthcare

IndustryMedical - Specialties

CEORobert A. Berman

Contact Information

https://www.envveno.com

Irvine, DE

Company Facts

37 Employees

IPO DateFeb 18, 2021

CountryUS

Frequently Asked Questions

;